Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Qiagen NV (QGEN)
NYSE:QGEN
QGEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$39.02 - $49.30
Previous CloseN/A
Volume260.87K
Average Volume (3M)1.35M
Market Cap
$8.71B
Enterprise Value$10.22B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)105.6
Beta0.73
Next Earnings
May 05, 2025EPS Estimate
0.49Last Dividend Ex-Date
Jan 29, 2025Dividend YieldN/A
Share Statistics
EPS (TTM)0.37
Shares Outstanding217,680,560
10 Day Avg. Volume1,628,901
30 Day Avg. Volume1,346,985
Standard Deviation0.06
R-Squared0.09
Alpha0.00122
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.17
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.36
Enterprise Value/Ebitda28.86
Forecast
1Y Price Target
$48.02Price Target Upside24.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
---
Qiagen News
PremiumCompany Announcements
Qiagen Exceeds 2024 Financial Outlook with Solid Growth
PremiumCompany Announcements
QIAGEN Reports Solid Growth and Exceeds 2024 Outlook---
Bulls Say, Bears Say
Bulls Say
Capital AllocationQiagen's capital allocation strategy includes potential bolt-ons and buybacks, with strong free cash flow providing optionality.
Operating MarginsManagement expressed confidence in the ability to grow operating margins past 30%, aided by operational initiatives and the wind-down of NeuMoDx.
Bears Say
Competitive PressuresCompetitive pressures could intensify, potentially limiting share price outperformance.
---
Ownership Overview
0.45% Insiders
19.60% Mutual Funds
0.07% Other Institutional Investors
65.42% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QGEN FAQ
What was Qiagen NV’s price range in the past 12 months?
Qiagen NV lowest stock price was $39.02 and its highest was $49.30 in the past 12 months.
What is Qiagen NV’s market cap?
Qiagen NV’s market cap is $8.71B.
When is Qiagen NV’s upcoming earnings report date?
Qiagen NV’s upcoming earnings report date is May 05, 2025 which is in 73 days.
How were Qiagen NV’s earnings last quarter?
Qiagen NV released its earnings results on Feb 05, 2025. The company reported $0.61 earnings per share for the quarter, missing the consensus estimate of $0.616 by -$0.006.
Is Qiagen NV overvalued?
According to Wall Street analysts Qiagen NV’s price is currently Undervalued.
Does Qiagen NV pay dividends?
Qiagen NV pays a Annually dividend of $1.259 which represents an annual dividend yield of N/A. See more information on Qiagen NV dividends here
What is Qiagen NV’s EPS estimate?
Qiagen NV’s EPS estimate is 0.49.
How many shares outstanding does Qiagen NV have?
Qiagen NV has 217,680,560 shares outstanding.
What happened to Qiagen NV’s price movement after its last earnings report?
Qiagen NV reported an EPS of $0.61 in its last earnings report, missing expectations of $0.616. Following the earnings report the stock price went down -3.105%.
Which hedge fund is a major shareholder of Qiagen NV?
Currently, no hedge funds are holding shares in QGEN
---
Qiagen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$48.02 (24.50% Upside)
$48.02 (24.50% Upside)
Blogger Sentiment
Bullish
QGEN Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.90%
12-Months-Change
Fundamentals
Return on Equity
2.27%
Trailing 12-Months
Asset Growth
-6.96%
Trailing 12-Months
Company Description
Qiagen NV
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
---
QGEN Company Deck
---
QGEN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Qiagen N.V. delivered a strong performance in Q4 2024, exceeding expectations in net sales and adjusted earnings, with significant growth in key product segments and improved profitability. However, challenges remain in specific regions and market segments, with cautious market conditions and declines in certain areas such as the Asia Pacific Japan region and Sample Technologies. Overall, the achievements and growth initiatives position the company well for future growth, despite current challenges.Read More>---
QGEN Stock 12 Month Forecast
Average Price Target
$48.02
▲(24.50% Upside)
Technical Analysis
Best Analysts Covering QGEN
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
+1.00%
reiterated a buy rating 8 months ago
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +1.00% per trade.
---